All News

Even before the COVID-19 pandemic, the pharmaceutical manufacturing sector was adopting digital technology to save time, cut costs and increase efficiencies in the value chain.

If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partn...

Manufacturing of active pharmaceutical ingredients has always been about innovating to cater for shifting demand patterns, but the recent coronavirus pandemic has raised further questions about whether the sector is doing enough to eke out efficiencies...

The collaboration aims to accelerate the development and commercialization of groundbreaking cell-based regenerative cures

Expanded global capacity addresses growing demand for cell and gene therapy

New report from Fitch Solutions points to greater consumer awareness of health insurance benefits in MENA region amid pandemic crisis and assesses individual countries' progress in vaccine procurement and rollout

AmpTec's differentiated PCR-based technology has shown to have advantages compared with other technologies for mRNA manufacturing

Which were the products that drew the most interest in the CPHI directory in December? We analyse search data from the CPHI directory…

Needle free systems offer compelling advantages for mass vaccination - could this be a potential platform for COVID19 vaccination programmes?

Increasing complexity of novel drugs and cost constraints have encouraged medicines administration to be shifted away from their traditional setting of a hospital or clinic to more cost-effective alternatives such as the patient’s own home. The a...

The new facility will house up to 12 X 2000-L bioreactors and will be equipped to handle existing and new advances in manufacturing

The company hopes its newly built fill and finish facility will assume commercial manufacturing this year

The $40 million investment marks the company's third viral vector manufacturing site

The CDMO will use its gene and cell therapy commercial expertise to bring "remarkable innovation" to young eligible patients

Acquisition will extend the Chinese CDMO’s European footprint and will complement Leverkusen drug product site

CDMO will add two production suites for clinical and commercial supply and extend lab space to double analytical and process development capacity

The third in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien

Newly formed generics business identifies the first five impacted plants as it seeks to reduce costs by $1 billion by the end of 2024

Two new facilities in Germany will provide clinical supply and cold chain services to support growing demand

Through the acquisition, Lilly will establish a gene therapy program via Prevail's gain clinical-stage and preclinical neuroscience assets

With a value of more than $1,000 billion in 2019 and enjoying a 5% increase during that year, the global pharmaceutical sector is in good health. But it is also a moving universe, in which both the digital and design revolutions have changed the game o...

The expansion will enable the CDMO to widen the nature of inhaled drug development projects it can undertake for customers

Dutch CDMO will expand with two additional viral vector production lines to meet the increased demand

The CDMO will provide packaging, labeling and distribution services through its FastChain demand-led supply offering

World’s largest syringe maker gears up for increased demand across all product classes amid expected COVID-19 vaccine roll out

UK-based CDMO makes ‘significant investment’ as companies combine HPAPI small molecule expertise with antibody drug conjugate specialism

COVID-19 has been a major focus for drug regulators on both sides of the Atlantic in 2020. But efforts to help industry combat the pandemic did not appear to have had a major impact on review activities judging by the drugs approved so far this year

The €160 million investment will double the company's single-use bioreactor mammalian cell-culture capacity

The first-of-its-kind manufacturing service delivers tested sterile, non-GMP media designed for feasibility testing before scale-up, to support development of cell and gene therapies

Industry customers now have access to 24/7 real-time shipment visibility across the company's entire product portfolio

The Eyesight Health Market is emerging and related products are a booming business. With age, aging and the overuse of electronics in work and life, especially in 2020, people are spending more time on smartphones, tablets and e-readers because of the ...

At Dr. Reddy’s, we’re in the business of ensuring good health for both people and the planet. Our experts will share insights on our sustainability approach and on how it helps B2B customers support their sustainable supply chain performance while sour...

Discover all key features and benefits of plastic coating options offered by SGD Pharma

If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner. ...

If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partn...

Which were the products that drew the most interest in the CPHI directory in November?

The company will invest in dedicated early-phase development and cGMP manufacturing to help customers rapidly advance challenging molecules

Twelve pharma market trends we anticipate across 2021 for the drug development, manufacturing and outsourcing sectors.

AZD1222 is 90% effective, cheap to produce and easy to store, distribute and administer

The CDMO is already making certain investments to enable technology transfer and scale-up to commence imminently.

The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market

Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market

The agreement comes hot on the heels of FDA approval of Gavreto — Blueprint Medicines' new treatment for lung cancer

Junker, B., Lester, M., Brix, T., Wong, D., & Nuechterlein, J. (2006). A next generation, pilot-scale continuous sterilization system for fermentation media. Bioprocess And Biosystems Engineering, 28(6), 

Data also show that mRNA-1273 remains stable at 2–8°, the temperature of a standard home or medical refrigerator, for 30 days.

The facility will be the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere.

Europeans set to benefit from the EC's authorization of COVID-19 candidate vaccine supply agreement, securing up to 405 million doses of CVnCoV

The specialist CDMO's $150 million 3-year investment plan will provide a complete suite of virotherapy services to support drug developers and their most "revolutionary" products.

Smart, connected devices are revolutionizing drug delivery in the ways they can gather, order and transmit crucial patient data to physicians

CPHI lifts the lid on the relatively little known German biotech and partner of Pfizer behind the most promising COVID19 vaccine candidate

Gareth Macdonald

The coronavirus pandemic has impacted biopharmaceutical manufacturing and is likely to continue to do so for years to come. But the pandemic is not the only thing changing how the industry goes about making medicines.

This phase sees the CDMO start work on installing two 2,000-L single-use bioreactor trains in its mammalian cGMP facility.

Results from a Phase III clinical study found Pfizer and BioNTech's mRNA-based vaccine candidate, BNT162b2, is more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection, the companies announced Monday...

Altimmune adds Lonza as a manufacturing partner for supply of AdCOVID, its single-dose intranasal vaccine candidate for COVID-19.

CMO growth, however, hampered by innovator approvals from mega-cap pharma.

For many years, well before the arrival of COVID-19, the pharmaceutical sector has faced increasing pressures, with challenges such as fake goods and grey market diversion. There is also increased emphasis on how to ensure patient adherence, as this di...

In this interview with Pharmapack, Arnaud Steiner, R&D Packaging Manager at Virbac shares his thoughts on trending issues in the packaging market such as patient centricity and eco-design, the challenges of managing the development of new packaging and...

New Pharmaceutical Excipients Will Change The Application Of Traditional Medicine

Propolis Cyclodextrin Inclusion Can Fight Stomach Cancer

Results suggest that it is possible to prepare a long-acting injection of fentanyl using SBE-β-CD as a solubilizer and a stabilizer

The Application Of Cyclodextrin In Paper

Company is the latest in a lengthening list of pharma companies recalling the diabetes medicine over unacceptable levels of NDMA

Device provides clinicians and trialists with comprehensive data on a patient's adherence pattern.

The expansion will entail building two new facilities - one in Germany, the other in Japan.

Initial stage of new facility planned for Ringaskiddy site to manufacture medicines for clinical trials.

The companies anticipate first results of Phase I/II in early December 2020, to support the initiation of a pivotal Phase III study before the end of the year.

As one of the world's leading providers of comprehensive security concepts, KURZ has developed a product protection solution for Covid-19 pharmaceuticals. It makes it possible to securely authenticate test kits and vaccines, and to track the flow of g...

Using continuous thermal sterilization improve your media sterilization in a continuous process.

Panel at CPHI Festival of Pharma discusses options for companies to ensure robust supply chains and reduce overseas supply dependency

The Russian Federation has become one of the first countries to apply to the WHO for prequalification of its vaccine, Sputnik V, against the novel coronavirus infection.

Pharma experts discuss the implications of the CPHI Annual Survey 

The ramping up of vaccine manufacturing demand amid the COVID-19 pandemic had an initial impact on cell and gene therapy production but the regenerative medicine sector has largely weathered the storm, according to senior industry figures in a recent p...

Company closes "key" plants in India, the US, Russia and Brazil as a precautionary measure.

The CRDMO will expand in vitro and in vivo biology services, DMPK and toxicology capabilities.

Dr Scott Gottlieb shares insights into COVID-19 vaccine development, the upcoming US election and pharma pricing at the CPHI Festival of Pharma

Key Milestones Indicate Transformational Power of AI and Machine Learning

Female life sciences leaders share their experiences and discuss the skills and attributes needed these days to become a successful leader and empower teams

The expansion at eight global Lonza sites will increase manufacturing capacity by 30 billion capsules annually.

By Duncan Emerton, PhD; Director, Custom Intelligence, Informa Pharma Intelligence

Rousselot and Faravelli announce Italian distribution partnership, effective from October 2020. Faravelli will distribute across Italy the Peptan, produced by Rousselot Health & Nutrition. They will also distribute pharmaceutical and food gelatins by R...

Now in its third edition, the Best Managed Companies Award is promoted by Deloitte to support and reward Italian companies.

The biopharma company collaborates with European and Canadian suppliers for large-scale ramp-up of opaganib manufacturing.

2021 will bring global pharma community back together, in person, to drive business growth.

The CDMO's Pathway TPUs are well-recognized as an effective option for many drug delivery systems.

CPHI Festival of Pharma webinar highlights challenges around detection and elimination of nitrosamine to keep pharmaceutical products safe

The recipe for efficiency by Universal Pack

MPA Technical Devices Srl is an Italian company specializing in designing and manufacturing top quality and accurate dosing systems.

CycloLab Cyclodextrin Research and Development Ltd. is a private SME with the focus on cyclodextrin research and development for over 30 years. We are working in the fields of pharmaceutical, cosmetic and food industry, agrochemical, environmental and ...

New ‘blockchain ecosystem’ has potential to track, from vein-to-vein, advanced therapies.

Manufacturing facility upgrades have substantially increased the CDMO’s production capacity and energy efficiency.

The technology eliminates the processing and performance challenges associated with conventionally coated delayed-release softgels.

Pushpa Vijayaraghavan  Director, Healthcare & Lifesciences Practice, Sathguru Management Consultants 

 

 

The rise of specialty and biologics has meant that one of the fastest growing segments by value today are Injectables demonstrating a 5-Year CAGR of 10%. This growth of course has implications and creates pressures across various areas such as treatmen...

Charbel Tengroth, Managing Director, Tengroth Consulting

With the Festival of Pharma now well and truly upon us, keep abreast of all that is happening and when over the ten days of this vast virtual event.

Festival of Pharma roundtable discusses how drug delivery formulation and development is focused on hospital-to-home care setting

Recipharm is pleased to announce that the results of the study with Erdosteine as an add-on treatment for COVID-19 patients are now available.

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced a EUR 2.6 million investment for additional manufacturing capacity to support increased demand into its Kaysersberg facility.

The investment will support increased demand and help to secure new business at its Kaysersberg facility.

The strategic acquisition of Axpharma is part of the group’s aim to widen its expertise and global reach as the pandemic forces renewed focus on safety, quality and speed-to-market.

Excellence in Pharma recognised at virtual ceremony taking place at the CPHI Festival of Pharma.

Akums’ journey of growth and expansion is a testimony to the company’s dedicated efforts in bringing novelty and eminence across its product range and services that meet the highest quality standards of all pharma companies and a well-deserved position...

The Indian Pharmaceutical market is expected to become the third largest in the world by the year 2020. India's largest contract manufacturing organization — Akums — manufactures 11-12% of all drugs consumed in India.

Investment includes the installation two of automated top-loading cartoner with the flexibility to pack vials, syringes, pens/autoinjectors and multi-component kits.

The expansion increases the company's capacity and provides its clients with larger process crystallization development, up to 20-L scale.

Former FDA Commissioner lays out roadmap for building out excess capacity to deal with pandemic situations

The facility will enable the company to deliver Phase I to commercial manufacturing services for biologic projects.

The CPHI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts, as well as the CPHI Pharma Industry Rankings (an annual executive survey of pharma pro...

Welcome to Week Two of the Festival of Pharma! In this podcast, Informa Markets Senior Content Producer, Diana Castro Sandoval, and Pharma Editor, Gareth Carpenter, reveal what's coming up on Day Six including a must-see keynote address from former FDA...

The CPHI Festival of Pharma is well underway! Tune into this podcast in which Informa Markets Head of Pharma Content, Tara Dougal, and Pharma Editor, Gareth Carpenter review some of the highlights of the first few days as well as a preview of what's co...

Discover Seqens CDMO

Evive’s F-627 candidate has shown promising results after several phase three clinical trials, CEO Liu Jubo says

Amgen’s second best-seller Neulasta, whose patent expired five years ago, generated US$3.2 billion of sales in 2019

As one of the fastest-growing economies in the Middle East region, Qatar is home to several industries that catalyze change and supply raw material for diverse products that form a major part of Qatar’s exports, thereby augmenting the nation’s economic...

Join us this Friday for the opening of our new formulation and sterile fill-finish facility with a digital open house from 1:00 to 2:00 pm EDT. Join key members of Alcami's operational and commercial leadership teams to learn about our newest faci...